February 10, 2010Exclusive Financial Advisory Agreement • February 11th, 2010 • Znomics, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 11th, 2010 Company Industry
LETTERHEAD] January 10, 1997 Confidential PharmaGenics, Inc. 4 Pearl Court Allendale, NJ 07401 Attention: Michael I. Sherman, Ph.D. Gentlemen: PaineWebber Incorporated ("PaineWebber") is pleased to act as exclusive financial advisor to PharmaGenics,...Exclusive Financial Advisory Agreement • April 8th, 1997 • Pharmagenics Inc /De/ • Pharmaceutical preparations
Contract Type FiledApril 8th, 1997 Company IndustryPaineWebber Incorporated ("PaineWebber") is pleased to act as exclusive financial advisor to PharmaGenics, Inc. (the "Company") and its affiliates in connection with any proposed sale transaction involving the Company and another party (a "Purchaser"), including Genzyme Corporation or any of its subsidiaries or affiliates ("Genzyme"). This Agreement supersedes in its entirety the engagement letter dated August 15, 1996. This Agreement confirms the terms of our engagement.
Attention: Board of Directors Re: Amending Agreement to Exclusive Financial Advisory AgreementExclusive Financial Advisory Agreement • July 30th, 2024
Contract Type FiledJuly 30th, 2024This letter will confirm our agreement to amend (the "Agreement") the financial advisory agreement between Xemoto Media Ltd. (the "Company") and FMI Capital Advisory Inc. ("FMICA") dated February 28, 2023 (the “Advisory Agreement"). FMICA and the Company, each a "party", hereinafter, collectively referred to as the “parties”).